EGFR is known to control GBP1 expression in glioblastoma and esophageal carcinoma [18–20], and (not surprisingly) we verified a positive correlation between EGFR and GBP1 expression levels when TNBC and non-TNBC tissues (Pearson correlation coefficient = 0.41; Fig. 4g, left panel) and cell lines (Pearson correlation coefficient = 0.67; Fig. 4g, right panel) were compared. Here, EGFR is linked to glioblastoma.